NASDAQ: TSVT - 2seventy bio, Inc.

Yield per half year: -49.31%
Sector: Healthcare

Share chart 2seventy bio, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

2seventy bio, Inc., компания, занимающаяся клеточной и генной терапией, специализируется на исследованиях, разработке и коммерциализации методов лечения рака в Соединенных Штатах. В ассортимент продукции компании входят idecabtagene vicleucel; ide-cel или Abecma и bb21217; и кандидаты на продукты CAR-T-клеток для лечения множественной миеломы. 2seventy bio, Inc. имеет соглашение о сотрудничестве с компанией Bristol-Myers Squibb. Компания была зарегистрирована в 2021 году, ее штаб-квартира находится в Кембридже, штат Массачусетс. 2seventy bio, Inc. (NasdaqGS: TSVT.

more details
V) работает независимо от bluebird bio, Inc. с 4 ноября 2021 года.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-11-03
ISIN US9013841070
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.2seventybio.com
Цена ао 2.42
Change price per day: -2.89% (2.49)
Change price per week: -8.41% (2.64)
Change price per month: -27.6% (3.34)
Change price per 3 month: -51.64% (5)
Change price per half year: -49.31% (4.77)
Change price per year: -35.35% (3.74)
Change price per 3 year: -81.24% (12.89)
Change price per 5 year: 0% (2.418)
Change price per 10 year: 0% (2.418)
Change price per year to date: -20.2% (3.03)
All parameters

Underestimation

Title Value Grade
P/S 1.95 7
P/BV 0.7663 9
P/E 0 0
EV/EBITDA -1.83 0
Total: 5.75

Efficiency

Title Value Grade
ROA, % -38.48 0
ROE, % -85.22 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -1.24 10
Total: 8.2

Growth impulse

Title Value Grade
Yield Revenue, % 128.15 10
Yield Ebitda, % -32.98 0
Yield EPS, % -67.94 0
Total: 2
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
03.06.2024 05.06.2024 Snow Jessica
See Remarks		 Sale 4.18 2 713 649 0 0 link
03.06.2024 05.06.2024 Eatwell Victoria
Chief Financial Officer		 Sale 4.18 4 878 1167 0 0 link
25.03.2024 25.03.2024 Casdin Capital, LLC
Director		 Purchase 5.07 1 673 100 330000 0 1.41 link
22.03.2024 25.03.2024 Casdin Capital, LLC
Director		 Purchase 5.12 754 570 147377 0 0.63 link
21.03.2024 25.03.2024 Casdin Capital, LLC
Director		 Purchase 4.9 1 470 000 300000 0 1.28 link
10.08.2023 16.08.2023 Kynam Global Healthcare Master
10% Owner		 Purchase 5.92 3 051 250 515414 0 2.21 link
10.08.2023 16.08.2023 Kynam Global Healthcare Master
10% Owner		 Purchase 5.96 515 027 86414 0 0.37 link

Institutions Volume Share, %
Kynam Capital Management, LP 6 11.58
Morgan Stanley 4 8.48
Goldman Sachs Group Inc 4 8.21
Blackrock Inc. 4 7.6
Vanguard Group Inc 4 7.26
Baker Brothers Advisors, LLC 3 4.86
Madison Avenue Partners, LP 2 4.73
Casdin Capital, LLC 2 3.89
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2 3.38
Point72 Asset Management, L.P. 2 3.14

ETF Share, % Profitability for 1 year, % Dividends, %
Range Cancer Therapeutics ETF 1.62889 47.24 0.11955
Global X Genomics & Biotechnology ETF 0.39133 2.58 0.15585
iShares Micro-Cap ETF 0.06251 13.79 1.54048
Avantis U.S Small Cap Equity ETF 0.02962 27.77 1.68271
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01703 15.15 1.75869
Motley Fool Next Index ETF 0.01393 23.87 0.61129
Vanguard Russell 2000 ETF 0.01 14.37 1.48801
Schwab U.S. Small-Cap ETF 0.0066 13.35 1.51433
ProShares UltraPro Russell2000 0.00533 89.82 1.47873
ProShares Hedge Replication ETF 0.0014 5.92 1.47892
Dimensional U.S. Targeted Value ETF 0.00104 26.01 1.93487
Schwab U.S. Broad Market ETF 0.00078 23.7 1.43354
iShares Russell 3000 ETF 0.00066 23.61 1.43482
Avantis U.S. Equity ETF 0.00033 20.45 1.59151
Dimensional U.S. Core Equity 2 ETF 0.00015 30.76 1.47098
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. William D. Baird III, M.B.A. CEO, President & Director 810.83k 1972 (53 years)
Ms. Victoria Eatwell Chief Financial Officer 1986 (39 years)
Ms. Jessica Snow Senior VP of Quality and Head of Operations 1979 (46 years)
Anna Truppel-Hartmann Chief Medical Officer

Address: United States, Cambridge. MA, 60 Binney Street - open in Google maps, open in Yandex maps
Website: https://www.2seventybio.com